Filtrování

    2026

    1. PROSECKÝ, Robert. Metabolický syndrom -komplexní pohled na patogenezi a nové terapeutické přístupy. ANGIS REVUE. Angis plus s.r.o., 2026. ISSN 2464-5435.

    2025

    1. PROSECKÝ, Robert. Farmakoterapie obezity: aktuální stav a perspektivy. ČESKÁ DIABETOLOGIE. We Make Media, s.r.o., 2018, 2025. ISSN 2571-0133.
    2. PROSECKÝ, Robert. Retratrutid: nový přístup v léčbě obezity, diabetu mellitu a MASLD. Klinická famakologie a farmacie. 2025, č. 39, s. 122-129. ISSN 1212-7973. Dostupné z: https://doi.org/10.36290/far.2025.041.

    2024

    1. GADANEC, Laura Kate; Kristen Renee MCSWEENEY; Peter KUBATKA; Martin CAPRNDA; Ludovit GASPAR; Robert PROSECKÝ; Jozef DRAGASEK; Peter KRUŽLIAK; Vasso APOSTOLOPOULOS a Anthony ZULLI. Angiotensin II constricts mouse iliac arteries: possible mechanism for aortic aneurysms. MOLECULAR AND CELLULAR BIOCHEMISTRY. DORDRECHT: SPRINGER, 2024, roč. 479, č. 2, s. 233-242. ISSN 0300-8177. Dostupné z: https://doi.org/10.1007/s11010-023-04724-0.
    2. SKERENOVA, Maria; Michal CIBULKA; Zuzana DANKOVA; Veronika HOLUBEKOVA; Zuzana KOLKOVA; Vincent LUCANSKY; Dana DVORSKA; Andrea KAPINOVA; Michaela KRIVOSOVA; Martin PETRAS; Eva BARANOVICOVA; Ivana BARANOVA; Elena NOVAKOVA; Peter LIPTAK; Peter BANOVCIN; Anna BOBCAKOVA; Robert ROSOLANKA; Maria JANICKOVA; Andrea STANCLOVA; Ludovit GASPAR; Martin CAPRNDA; Robert PROSECKÝ; Monika LABUDOVA; Zufar GABBASOV; Luis RODRIGO; Peter KRUŽLIAK; Zora LASABOVA; Tatiana MATAKOVA a Erika HALASOVA. Host genetic variants associated with COVID-19 reconsidered in a Slovak cohort. Advances in Medical Sciences. WROCLAW: ELSEVIER URBAN & PARTNER SP Z O O, 2024, roč. 69, č. 1, s. 198-207. ISSN 1896-1126. Dostupné z: https://doi.org/10.1016/j.advms.2024.03.007.
    3. PEKAŘ, Matej; Otakar JIRAVSKÝ; Jan NOVÁK; Piotr BRANNY; Jakub BALUŠÍK; Daniel DANIŠ; Jan HEČKO; Marek KANTOR; Robert PROSECKÝ; Lubomír BLAHA a Radek NEUWIRTH. Sarcopenia and adipose tissue evaluation by artificial intelligence predicts the overall survival after TAVI. SCIENTIFIC REPORTS. BERLIN: NATURE PORTFOLIO, 2024, roč. 14, č. 1, s. 1-9. ISSN 2045-2322. Dostupné z: https://doi.org/10.1038/s41598-024-59134-z.

    2023

    1. PROSECKÝ, Robert; Šárka KUNZOVÁ; Petra KOVACOVICOVA; Mária HRABČAKOVÁ; Pavel HOMOLKA; Ondřej SOCHOR; Peter KRUŽLIAK; Laura Kate GADANEC; Ladislav SOUKUP a Jan NOVÁK. Association of anthropometric and body composition parameters with the presence of hypertension in the Central European population: results from KardioVize 2030 study. Acta Cardiologica. OXON: TAYLOR & FRANCIS LTD, 2023, roč. 78, č. 5, s. 614-622. ISSN 0001-5385. Dostupné z: https://doi.org/10.1080/00015385.2023.2192153.
    2. MCSWEENEY, Kristen Renee; Laura Kate GADANEC; Peter KUBATKA; Martin CAPRNA; Ludovit GASPAR; Robert PROSECKÝ; Delian DELEV; Peter KRUŽLIAK; Vasso APOSTOLOPOULOS a Anthony ZULLI. Cisplatin treatment reduces contraction to angiotensin II by altering expression of angiotensin II receptors: a pilot study. MOLECULAR AND CELLULAR BIOCHEMISTRY. NETHERLANDS: SPRINGER, 2023, roč. 478, č. 12, s. 2907-2916. ISSN 0300-8177. Dostupné z: https://doi.org/10.1007/s11010-023-04706-2.
    3. SAMEC, Marek; Alena MAZURAKOVA; Vincent LUCANSKY; Lenka KOKLESOVA; Renata PECOVA; Martin PEC; Olga GOLUBNITSCHAJA; Raghad Khalid AL-ISHAQ; Martin CAPRNDA; Ludovit GASPAR; Robert PROSECKÝ; Katarina GAZDIKOVA; Mariusz ADAMEK; Dietrich BUESSELBERG; Peter KRUŽLIAK a Peter KUBATKA. Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2. European Journal of Pharmacology. AMSTERDAM: Elsevier, 2023, roč. 949, June 2023, s. 1-19. ISSN 0014-2999. Dostupné z: https://doi.org/10.1016/j.ejphar.2023.175655.
    4. MAZURAKOVA, Alena; Zuzana SOLAROVA; Lenka KOKLESOVA; Martin CAPRNDA; Robert PROSECKÝ; Artur KHAKYMOV; Denis BARANENKO; Peter KUBATKA; Ladislav MIROSSAY; Peter KRUŽLIAK a Peter SOLAR. Heat shock proteins in cancer - Known but always being rediscovered: Their perspectives in cancer immunotherapy. Advances in Medical Sciences. WROCLAW: ELSEVIER URBAN & PARTNER SP Z O O, 2023, roč. 68, č. 2, s. 464-473. ISSN 1896-1126. Dostupné z: https://doi.org/10.1016/j.advms.2023.10.005.
    5. ZAGATINA, Angela; Elena KALININA; Martin CAPRNDA; Ludovit GASPAR; Katarina GAZDIKOVA; David ULLRICH; Robert PROSECKÝ; Luis RODRIGO a Peter KRUŽLIAK. Prognostic value of Doppler echocardiographic coronary flow velocity assessment at rest in elderly patients. Acta Cardiologica. ABINGDON: TAYLOR & FRANCIS LTD, 2023, roč. 78, č. 4, s. 409-416. ISSN 0001-5385. Dostupné z: https://doi.org/10.1080/00015385.2022.2121538.
    6. MYTSYK, Yulian; Yosyf NAKONECHNYI; Victor DOSENKO; Pawel KOWAL; Michal PIETRUS; Katarina GAZDIKOVA; Monika LABUDOVA; Martin CAPRNDA; Robert PROSECKÝ; Jozef DRAGASEK; Peter KRUŽLIAK a Roman DATS. The performance and limitations of PCA3, TMPRSS2:ERG, HOXC6 and DLX1 urinary markers combined in the improvement of prostate cancer diagnostics. Clinical Biochemistry. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD, 2023, roč. 116, June 2023, s. 120-127. ISSN 0009-9120. Dostupné z: https://doi.org/10.1016/j.clinbiochem.2023.04.011.

    2022

    1. MAZURAKOVA, Alena; Lenka KOKLESOVA; Marek SAMEC; Erik KUDELA; Jana SIVAKOVA; Terezia PRIBULOVA; Martin Jozef PEC; Martin PEC; Martin KELLO; Dietrich BUSSELBERG; Olga GOLUBNITSCHAJA; Ludovit GASPAR; Martin CAPRNDA; Mariusz ADAMEK; Robert PROSECKÝ; Elmira EMINOVA; Denis BARANENKO; Peter KRUŽLIAK; Peter KUBATKA a Kamil BIRINGER. Flavonoids exert potential in the management of hypertensive disorders in pregnancy. PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH. OXFORD: ELSEVIER SCI LTD, 2022, roč. 29, August 2022, s. 72-85. ISSN 2210-7789. Dostupné z: https://doi.org/10.1016/j.preghy.2022.06.007.

    2021

    1. LISKOVA, A.; M. SAMEC; L. KOKLESOVA; S. M. SAMUELSM; K. V. ZHAI; R. K. AL-ISHAQ; M. ABOTALEB; V. NOSAL; K. KAJO; M. ASHRAFIZADEH; A. ZARRABI; A. BROCKMUELLER; M. SHAKIBAEI; P. SABAKA; I. MOZOS; D. ULLRICH; Robert PROSECKÝ; G. LA ROCCA; M. CAPRNDA; D. BUSSELBERG; L. RODRIGO; Peter KRUŽLIAK a P. KUBATKA. Flavonoids against the SARS-CoV-2 induced inflammatory storm. BIOMEDICINE & PHARMACOTHERAPY. Paris: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2021, roč. 138, June 2021, s. 1-12. ISSN 0753-3322. Dostupné z: https://doi.org/10.1016/j.biopha.2021.111430.
    2. GABBASOV, Z. A.; Y. N. AVTAEVA; I. S. MELNIKOV; S. D. OKHOTA; M. CAPRNDA; I. MOZOS; Robert PROSECKÝ; L. RODRIGO; Peter KRUŽLIAK a N. I. ZOZULYA. Kinetics of platelet adhesion to a fibrinogen-coated surface in whole blood under flow conditions. JOURNAL OF CLINICAL LABORATORY ANALYSIS. HOBOKEN: WILEY, 2021, roč. 35, č. 9, s. 1-9. ISSN 0887-8013. Dostupné z: https://doi.org/10.1002/jcla.23939.
    3. JASEK, Karin; Marian GRENDAR; Andrea STANCLOVA; Bibiana MALICHEROVA; Ivana KASUBOVA; Tatiana BURJANIVOVA; Peter SZEPE; Rachele CICCOCIOPPO; Luis RODRIGO; Robert PROSECKÝ; Peter KRUŽLIAK; Lukas PLANK a Zora LASABOVA. Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients. Journal of cancer research and clinical oncology. Germany: Springer-Verlag, 2021, roč. 147, č. 4, s. 1203-1215. ISSN 0171-5216. Dostupné z: https://doi.org/10.1007/s00432-020-03410-8.

    2020

    1. SAMEC, Marek; Alena LISKOVA; Lenka KOKLESOVA; Samson Mathews SAMUEL; Radovan MURIN; Pavol ZUBOR; Jan BUJNAK; Taeg Kyu KWON; Dietrich BUSSELBERG; Robert PROSECKÝ; Martin CAPRNDA; Luis RODRIGO; Rachele CICCOCIOPPO; Peter KRUŽLIAK a Peter KUBATKA. The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis. Journal of cancer research and clinical oncology. Germany: Springer-Verlag, 2020, roč. 146, č. 12, s. 3137-3154. ISSN 0171-5216. Dostupné z: https://doi.org/10.1007/s00432-020-03424-2.

    2019

    1. KOVACIC, Alenka Premuš Marušič; Martin CAPRNDA; Aleš MRHAR; Peter KUBATKA; Igor LOCATELLI; Barbora ZOLAKOVA; Ludovit GASPAR; Robert PROSECKÝ; Peter KRUŽLIAK; Robert STAFFA; Luis RODRIGO; Jozef RADONAK a Danijel PETROVIC. Impact of drugs on venous thromboembolism risk in surgical patients. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. HEIDELBERG: SPRINGER HEIDELBERG, 2019, roč. 75, č. 6, s. 751-767. ISSN 0031-6970. Dostupné z: https://doi.org/10.1007/s00228-019-02636-x.

    2014

    1. SOCHOR, Ondřej; Eva KRÁLÍKOVÁ; Renata CÍFKOVÁ; Jindřich FIALA; Iva TOMÁŠKOVÁ; Šárka KUNZOVÁ; Jiří LEŠOVSKÝ; Zdeněk PLUHÁČEK; Hana NECHUTOVÁ; Pavel ŘIMÁK; Veronika ŠIKOLOVÁ; Martin HOMOLKA; Radka ŠTĚPÁNOVÁ; Jiří VÍTOVEC; Tomáš KÁRA; Robert PROSECKÝ; Peter WOHLFAHRT; Vladimír SOŠKA a Francisco LOPEZ-JIMENEZ. Tobacco use and some characteristics of tobacco users. Preliminary results of ‘‘Kardiovize Brno 2030. Cor et Vasa. Brno: Česká kardiologická společnost, 2014, roč. 56, č. 2, s. "e118"-"e127", 10 s. ISSN 0010-8650.

    2011

    1. MELUZÍN, Jaroslav; Helena PODROUŽKOVÁ; Jan SITAR; Jan KŘÍSTEK; Robert PROSECKÝ; Martin PEŠL; Lada RAMBOUSKOVÁ; Vladimír SOŠKA a Roman PANOVSKÝ. Které echokardiografické parametry potřebujeme pro diagnostiku primárního diastolického srdečního selhání? Cor et Vasa. 2011, roč. 53, č. 11, s. 630-636, 6 s. ISSN 0010-8650.
    2. MELUZÍN, Jaroslav; Jan SITAR; Jan KŘÍSTEK; Robert PROSECKÝ; Martin PEŠL; Helena PODROUŽKOVÁ; Vladimír SOŠKA; Roman PANOVSKÝ a Ladislav DUŠEK. The role of exercise echocardiography in the diagnostics of heart failure with normal left ventricular ejection fraction. European Journal of Echocardiography. 2011, roč. 12, č. 8, s. 591–602. ISSN 1525-2167. Dostupné z: https://doi.org/10.1093/ejechocard/jer082.
Zobrazit podrobně